Torre Fornell

French biotech company Aelis Farma, specializing in the treatment of brain disorders announced positive results Monday from a Phase 1/2 trial of its drug candidate AEF0217 in young adults with Down syndrome. The study, conducted in Spain, assessed the safety, tolerability and potential efficacy of...